HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
暂无分享,去创建一个
C. Wysham | M. Ingham | P. Lefebvre | M. Pfeifer | D. Pilon | M. Lafeuille | Rhiannon L. Kamstra | B. Emond